###### Strengths and limitations of this study

-   To our knowledge, this study is the first to empirically examine whether Hawthorne effects may have influenced study results in an HIV prevention trial.

-   We analysed longitudinal data on a key study outcome (school enrolment) for the underlying population from which study participants were drawn. Complete data are not typically available for source populations in research studies.

-   Our Hawthorne-specific findings suggest that aspects of the HIV Prevention Trial Network (HPTN) 068 protocol could potentially be adapted for school retention interventions to prevent HIV.

-   It is important to note that data on HIV incidence, the primary endpoint of HPTN 068, were not available for the underlying target population.

-   The differences we attribute to the Hawthorne effect were estimated in an observational data set with adjustment for key sociodemographic characteristics. The potential for uncontrolled confounding requires that our results be interpreted cautiously.

Introduction {#s1}
============

The evidence base for public health interventions largely comes from rigorous epidemiological studies.[@R1] However, results from epidemiological studies may not be generalisable (or 'externally valid') when study participant characteristics differ from those in the target population, even with randomisation of exposure (referred to here as 'sample selection effect').[@R3] Further threats to validity can occur if study participation itself induces behaviour change (Hawthorne effect, research participation effect or trial effect, referred to here, collectively, as 'Hawthorne effect').[@R4] Analysing study data to examine how results may have differed in the target population to which we would like to make inference is critical to making valid conclusions and policy recommendations.

Although epidemiological training and research have long included at least cursory examinations of external validity,[@R6] with more recent methodological advancements around transportability of effect estimates from study populations to target populations,[@R7] empirical evaluation of Hawthorne effects is rare. The limited evidence for Hawthorne effects comes largely from clinical randomised controlled trials, most often assessed in cancer and nutrition studies,[@R10] with supporting evidence from HIV treatment research.[@R12] Trials designed to affect behaviour change may be particularly susceptible to Hawthorne effects as the behaviours in question may be influenced by trial participation.[@R13] This is particularly true in HIV prevention research, where Hawthorne effects could pose validity threats if unexpectedly low HIV incidence occurs due to trial-induced risk behaviour changes.[@R15] To our knowledge, no prior HIV prevention trial has empirically examined whether Hawthorne effects influenced study results.

In this study, we examine the potential influence of both sample selection effects and Hawthorne effects in the behavioural HIV Prevention Trial Network (HPTN) 068 study,[@R16] designed to examine whether cash transfers conditional on school attendance reduce HIV acquisition in young South African women. Contrary to the study hypothesis, no difference in HIV acquisition was observed between study arms, with high levels of school enrolment and low HIV incidence in both arms. These findings were surprising given the high background rates of school dropout in the study area[@R18] and the large body of evidence showing the positive impact of cash transfers on schooling outcomes,[@R21] and limited the ability to explore schooling as a mechanism to reduce HIV risk.

Here, we contextualise HPTN 068 findings, using data on school enrolment in the underlying target population routinely collected by the Agincourt Health and socio-Demographic Surveillance System (HDSS) in which HPTN 068 was nested. We examine whether school enrolment trajectories of trial participants differed from non-participants, and whether differences could be attributed to existing differences in school enrolment at baseline (sample selection effect) or differences that arose during study participation (Hawthorne effect).

Methods {#s2}
=======

Study setting and population {#s2a}
----------------------------

The Agincourt HDSS is located in the rural Bushbuckridge municipality of the Mpumalanga province, South Africa,[@R22] and has routinely collected annual vital event data on all people living in the study area since 1992. Other sociodemographic data are collected at regular but less frequent intervals. For example, educational attainment is queried every 3 years, employment data are collected every 4 years, and a household asset index is measured every other year. Community, household and individual consents have been obtained for all Agincourt HDSS census research since its inception, with informed verbal consent obtained at each census round. The Agincourt HDSS currently surveys the full cohort of over 115 000 people living across 31 villages, in an area of economic disadvantage with historically low access to public services. However, government schools in the study site are free and often provide feeding programmes. HIV contributes a large burden to the community, with 19% HIV prevalence overall in those aged 15 years and older.[@R23]

HPTN 068 was a phase III individually randomised trial designed to examine whether cash transfers conditional on school attendance influence the risk of HIV acquisition in young women.[@R16] Young women and their caregivers were randomly assigned to receive a monthly cash transfer conditional on ≥80% school attendance or no cash transfer. The size of the monthly cash transfer was 300 rands (R; about US\$30 in 2012), and was divided into R200 provided to the caregiver and R100 provided to the young woman. Key selection criteria for participation in the study were current enrolment in grades 8--11; age 13--20 years; not married or pregnant at baseline; and having a caregiver with the documents necessary to open a bank account. Age-eligible young women were identified from Agincourt HDSS records to be contacted for further eligibility screening (n=10 134).[@R16] Between March 2011 and December 2012, a total of 2533 young women were enrolled. Participants were seen annually for a maximum of 3 years from enrolment or until high school graduation. Thus, participants who enrolled in the trial in 2011 in grade 11 could exit the study as early as 2012 after graduating high school. Participants who enrolled in the trial in 2012 in grade 8 or 9 could exit the study as late as March 2015 ([figure 1](#F1){ref-type="fig"}).

![Timeline of Agincourt HDSS education data collection and HPTN 068 trial duration. HDSS, Health and socio-Demographic Surveillance System; HPTN, HIV Prevention Trial Network.](bmjopen-2017-019167f01){#F1}

Cohort construction {#s2b}
-------------------

We constructed our analytical cohort to identify all young women living in the study area at the time of trial start (2011) regardless of trial participation status. Further restrictions were applied to build a cohort of young women on comparable age/grade trajectories and to match key HPTN 068 selection criteria. First, we restricted the cohort to include young women between the ages of 13 and 20 years in 2011 or 2012. Based on education data collected by the Agincourt HDSS in 2009 (education data were collected in 2009 but not again until 2012), we also restricted the cohort to those who were enrolled in grades that projected to grades 8--11 in 2011 or 2012, assuming a one-grade increase each year.

Key measures {#s2c}
------------

Our primary exposure of interest was *HPTN 068 trial participation* (both trial arms combined). We analysed both arms together because trial results indicated essentially no differences in school attendance and enrolment data between the arms. School attendance was high (≥80%) for 95% of the intervention arm and 96% of the control arm participants. Permanent school dropout occurred at a rate of 3 per 100 person years in both arms.[@R17]

Our primary outcome of interest was *school enrolment*, which we calculated at 2011 and 2015 based on Agincourt HDSS education data collected in 2009, 2012 and 2015. We used the 2011 school enrolment outcome to assess whether enrolment patterns were already different at the beginning of the trial, indicating a potential sample selection effect. We used the 2015 school enrolment outcome to assess whether enrolment patterns were different at the end of the trial, when both sample selection and Hawthorne effects could be present. We considered young women as enrolled in school if they indicated current school enrolment or if they reported a grade 12 attainment, the final year of secondary schooling.

With the 2009, 2012 and 2015 education modules, fieldworkers updated the highest education level each young woman achieved and recorded whether or not she was currently enrolled in school. The 2015 time-point aligned with a census education module, so enrolment status decisions were made based on data reported at that time. The 2011 time-point did not align with a census education module, so we inferred enrolment status at this time-point based on changes in status between 2009 and 2012. If young women reported enrolment in both 2009 and 2012, we inferred they were also enrolled in 2011. If young women reported enrolment in 2009 but not 2012, we used changes in educational attainment to infer whether school dropout had occurred before or after 2011. For example, if a young woman reported grade 7 attainment in 2009 and grade 10 attainment in 2012, we assumed that the 3 years of additional education were accumulated in 2009, 2010 and 2011. This young woman would be coded as enrolled in school in 2011. If a young woman reported grade 7 attainment in 2009 and grade 9 attainment in 2012, we assumed that the 2 years of additional education were accumulated in 2009 and 2010. This young woman would be coded as not enrolled in school in 2011. Observations with illogical education data patterns between 2009 and 2012 (eg, educational attainment decreases over time) were coded as missing for school enrolment in 2011.

We also explored the potential for confounding and effect measure modification by key covariates. We examined age on 1 January 2011, categorised as ages of compulsory school enrolment (ages 11--15 years), older than age for compulsory school enrolment but correct age for grade (ages 16--17 years), and older than age for compulsory school enrolment while also older than expected for grade (ages 18--20 years). We also examined indicators of household socioeconomic status (SES), measured with a composite index of household assets; household size; gender of household head; secondary school educational attainment of the household head; country of origin (South African or Mozambican descent); and pre-2011 childbearing.

Analysis {#s2d}
--------

We used binomial regression models with an identity link to estimate the association between trial participation and school enrolment in 2011 and 2015. The 2011 enrolment outcome was used to isolate the potential for a sample selection effect (ie, Were trial participants more likely to be in school than non-participants at the beginning of the trial?). We used the 2015 enrolment outcome in a restricted cohort of young women who were enrolled in school in 2011 to isolate the potential for a Hawthorne effect at the end of the trial (ie, Were trial participants more likely to remain in school after 4 years than non-participants, conditional on being in school at the beginning of the trial?).

We conducted unadjusted analyses and analyses adjusted for age, SES, gender and education of household head, household size, country of origin, and pre-2011 childbearing. School enrolment decisions were likely highly influenced by age both because our cohort straddled the age limit for compulsory schooling in South Africa and because school dropout generally increases with age. Thus, we conducted age-stratified analyses to see whether the associations between trial participation and school enrolment differed by age category.

Although trial results indicated that school attendance and enrolment outcomes were not significantly different between the arms of the trial, the intervention was designed to incentivise school attendance.[@R17] For this reason, we conducted a sensitivity analysis restricting the trial participants to those who were randomly assigned to the control group only. We compared results from this restricted population with the results from the analysis of the full trial population.

Results {#s3}
=======

Overall 3889 young women from the Agincourt HDSS were included in our cohort ([table 1](#T1){ref-type="table"}). The median age was 15 years (IQR: 14--16). Young women tended to live in large households (mean size: 8.4), and household heads were often female (42%) and often lacked high school education (86%). The majority of young women were of South African descent (60%) and very few (7%) had begun childbearing prior to 2011. Just under half of the young women (44%) went on to participate in HPTN 068, and they tended to be less likely to be on the youngest (ages 11--12) or oldest (ages 19--20) end of the age spectrum, although the median age of both participants and non-participants was 15. Trial participants were also less likely to have begun childbearing, slightly more likely to live in households headed by high school graduates and slightly more likely to live in household with above-median SES.

###### 

Sociodemographic characteristics of a cohort of 3889 young women between the ages of 11 and 20 years in rural Agincourt, South Africa, by participation in the HPTN 068 trial

                                                                     Total (n=3889)   Trial participant[\*](#tblfn1){ref-type="fn"} (n=1720)   Non-participant (n=2169)   P value[†](#tblfn2){ref-type="fn"}                 
  ------------------------------------------------------------------ ---------------- -------------------------------------------------------- -------------------------- ------------------------------------ ------ ------ ----------
  Age in 2011                                                                                                                                                                                                                \<0.0001
   11--12                                                            188              4.8                                                      26                         1.5                                  162    7.5    
   13--14                                                            1270             32.7                                                     637                        37.0                                 633    29.2   
   15--16                                                            1591             40.9                                                     793                        46.1                                 798    36.8   
   17--18                                                            667              17.2                                                     239                        13.9                                 428    19.7   
   19--20                                                            173              4.5                                                      25                         1.5                                  148    6.8    
  SES[‡](#tblfn3){ref-type="fn"}                                                                                                                                                                                             0.003
   At or above median                                                1778             50                                                       853                        52.7                                 925    47.8   
   Below median                                                      1778             50                                                       766                        47.3                                 1012   52.3   
   Missing                                                           333                                                                       101                                                             232           
  Household size[‡](#tblfn3){ref-type="fn"}                                                                                                                                                                                  0.5
   Mean                                                              8.4                                                                       8.4                                                             8.5           
   SD                                                                4.2                                                                       4.0                                                             4.4           
   Missing                                                           46                                                                        14                                                              32            
  Gender of household head[‡](#tblfn3){ref-type="fn"}                                                                                                                                                                        0.3
   Female                                                            1590             41.7                                                     691                        40.8                                 899    42.4   
   Male                                                              2224             58.3                                                     1004                       59.2                                 1220   57.6   
   Missing                                                           75                                                                        25                                                              50            
  Household head educational attainment[‡](#tblfn3){ref-type="fn"}                                                                                                                                                           0.02
   \<Grade 12                                                        3062             86.3                                                     1398                       87.8                                 1664   85.1   
   Grade 12 or higher                                                486              13.7                                                     194                        12.2                                 292    14.9   
   Missing                                                           341                                                                       128                                                             213           
  Country of origin[‡](#tblfn3){ref-type="fn"}                                                                                                                                                                               0.2
   South Africa                                                      2315             59.6                                                     1046                       60.9                                 1269   58.6   
   Mozambique                                                        1570             40.4                                                     673                        39.2                                 897    41.4   
   Missing                                                           4                                                                         1                                                               3             
  Childbearing before 2011                                                                                                                                                                                                   \<0.0001
   Yes                                                               274              7.1                                                      67                         3.9                                  207    9.5    
   No                                                                3615             93.0                                                     1653                       96.1                                 1962   90.5   
  Intervention arm                                                                                                                                                                                                           
   Control                                                                                                                                     820                        50.4                                               
   Intervention                                                                                                                                806                        49.6                                               
  2011 school enrolment                                                                                                                                                                                                      \<0.0001
   Yes                                                               3508             95.7                                                     1637                       99.2                                 1871   92.9   
   No                                                                158              4.3                                                      14                         0.9                                  144    7.2    
   Missing                                                           223                                                                       69                                                              154           
  2015 school enrolment                                                                                                                                                                                                      \<0.0001
   Yes                                                               2465             74.2                                                     1234                       19                                   1231   68.5   
   No                                                                856              25.8                                                     290                        81                                   566    31.5   
   Missing                                                           568                                                                       196                                                             372           

\*Due to restrictions in the cohort construction to maintain comparable groups with respect to age and education status in 2009, not all of the 2533 HPTN 068 participants are represented.

†P values for categorical variables are from Χ^2^ tests and for continuous variables from t-tests.

‡Measured in 2009.

HPTN, HIV Prevention Trial Network; SES, socioeconomic status.

In 2011, at the time of HPTN 068 trial start, nearly everyone in the cohort was enrolled in school (96%), likely due to the age and 2009 enrolment requirements placed on the cohort ([table 2](#T2){ref-type="table"}). However, young women who became trial participants were already more likely to be enrolled in school (99%) compared with non-participants (93%) (risk difference (95% CI): 6.3 (5.1 to 7.5)), indicating a sample selection effect likely occurred as a consequence of the school enrolment eligibility criterion. Although the overall association attenuated after covariate adjustment (adjusted risk difference (aRD) (95% CI): 2.9 (−0.7 to 6.5)), strong associations were observed in the age group of 18--20 years old (aRD (95% CI): 19.5 (5.6 to 33.3)), compared with the younger two age groups (aRD~11--15~ (95% CI): 0.4 (−5.2 to 5.9); aRD~16--17~ (95% CI): 6.3 (0.5 to 12.2)).

###### 

The relationship between HPTN 068 trial participation and school enrolment in 2011 and 2015, stratified by age, in the full cohort and the cohort restricted to those enrolled in school in 2011

                                                       Enrolment   n      Per cent enrolled   RD (95% CI)           aRD[\*](#tblfn5){ref-type="fn"} (95% CI)
  ---------------------------------------------------- ----------- ------ ------------------- --------------------- ------------------------------------------
  2011: full cohort                                                                                                 
  All ages                                                                                                          
   Trial participant                                   1637        1651   99.2 (98.7, 99.6)   6.3 (5.1 to 7.5)      2.9 (−0.7 to 6.5)
   Non-trial participant                               1871        2015   92.9 (91.7, 94.0)   1                     1
  Ages 11--15                                                                                                       
   Trial participant                                   1036        1038   99.8 (99.5, 1.00)   0.6 (0.0 to 1.2)      0.4 (−5.2 to 5.9)
   Non-trial participant                               1115        1124   99.2 (98.6, 99.7)   1                     1
  Ages 16--17                                                                                                       
   Trial participant                                   532         539    98.7 (97.8, 99.7)   6.9 (4.6 to 9.2)      6.3 (0.5 to 12.2)
   Non-trial participant                               593         646    91.8 (89.7, 93.9)   1                     1
  Ages 18--20                                                                                                       
   Trial participant                                   69          74     93.2 (87.5, 99.0)   26.7 (18.5 to 34.9)   19.5 (5.6 to 33.3)
   Non-trial participant                               163         245    66.5 (60.6, 72.4)   1                     1
  2015: full cohort                                                                                                 
  All ages                                                                                                          
   Trial participant                                   1234        1524   81.0 (79.0, 83.0)   12.5 (9.6 to 15.4)    6.8 (3.4 to 10.2)
   Non-trial participant                               1231        1797   68.5 (66.4, 70.7)   1                     1
  Ages 11--15                                                                                                       
   Trial participant                                   837         952    87.9 (85.9, 90.0)   3.8 (0.1 to 6.9)      1.9 (− 1.3 to 5.0)
   Non-trial participant                               833         990    84.1 (81.9, 86.5)   1                     1
  Ages 16--17                                                                                                       
   Trial participant                                   361         503    71.8 (67.9, 75.8)   12.5 (6.9 to 18.1)    12.7 (6.7 to 18.7)
   Non-trial participant                               346         584    59.3 (55.4, 63.4)   1                     1
  Ages 18--20                                                                                                       
   Trial participant                                   36          69     52.2 (41.6, 65.4)   28.9 (15.8 to 41.9)   29.7 (16.1 to 43.3)
   Non-trial participant                               52          223    23.3 (18.4, 29.6)   1                     1
  2015: restricted cohort[†](#tblfn6){ref-type="fn"}                                                                
  All ages                                                                                                          
   Trial participant                                   1234        1510   81.7 (79.8, 83.7)   7.3 (4.5 to 10.2)     4.9 (1.5 to 8.3)
   Non-trial participant                               1231        1655   74.4 (72.3, 76.5)   1                     1
  Ages 11--15                                                                                                       
   Trial participant                                   837         950    88.1 (86.1, 90.2)   3.2 (0.2 to 6.3)      1.8 (−1.3 to 5.0)
   Non-trial participant                               833         982    84.8 (82.6, 87.1)   1                     1
  Ages 16--17                                                                                                       
   Trial participant                                   361         496    72.8 (69.0, 76.8)   7.6 (1.9 to 13.3)     7.9 (1.9 to 14.0)
   Non-trial participant                               346         531    65.2 (61.2, 69.3)   1                     1
  Ages 18--20                                                                                                       
   Trial participant                                   36          64     56.3 (45.3, 69.8)   19.6 (5.1 to 34.1)    22.8 (7.3 to 38.2)
   Non-trial participant                               52          142    36.6 (29.5, 45.5)   1                     1

\*Adjusted for socioeconomic status (coded dichotomously at median household asset index score), country of origin (South African vs Mozambican), educational attainment of household head (coded dichotomously at grade 12 attainment), gender of household head (male vs female), household size (coded linearly) and pre-2011 childbearing (yes vs no). Models that are not age-stratified are also adjusted for age coded in 2-year categories.

†Restricted to all young women who were enrolled in school in 2011.

aRD, adjusted risk difference; HPTN, HIV Prevention Trial Network; RD, risk difference.

At the end of the trial in 2015, the difference in school enrolment between trial participants (81%) and non-participants (69%) grew, with an adjusted overall risk difference of 6.8 (95% CI 3.4 to 10.2). To investigate whether any differences in school enrolment could be attributed to a Hawthorne effect, we restricted the cohort to those enrolled in school in 2011 and examined differences in 2015. Under this restriction, young women enrolled in the trial were still more likely to remain in school in 2015 (82%), compared with those who did not (74%), with an aRD of 4.9 (95% CI 1.5 to 8.3)). Again, the association was weakest among those 11--15 years old (aRD (95% CI): 1.8 (−1.3 to 5.0)) and strongest among those 18--20 years old (aRD (95% CI): 22.8 (7.3 to 38.2)).

Results were largely unchanged when we restricted the trial participant population to those assigned to the control group only ([table 3](#T3){ref-type="table"}). Although CIs widened due to reduced sample size with some newly spanning the null, the magnitudes of the risk difference point estimates were largely unchanged from those in the primary analysis.

###### 

Sensitivity analysis comparing differences in school enrolment between HPTN 068 trial participants in the control arm only and non-trial participants

                                                        Enrolment   n      Per cent enrolled   RD (95% CI)           aRD\* (95% CI)
  ----------------------------------------------------- ----------- ------ ------------------- --------------------- ---------------------
  2011: full cohort                                                                                                  
  All ages                                                                                                           
   Trial participant (control)                          862         872    98.9 (98.2, 99.6)   6.0 (4.7 to 7.3)      3.2 (−1.4 to 7.7)
   Non-trial participant                                1871        2015   92.9 (91.7, 94.0)   1                     1
  Ages 11--15                                                                                                        
   Trial participant (control)                          543         544    99.8 (99.5, 1.00)   0.6 (0.0 to 1.3)      0.4 (−7.3 to 8.0)
   Non-trial participant                                1115        1124   99.2 (98.6, 99.7    1                     1
  Ages 16--17                                                                                                        
   Trial participant (control)                          280         285    98.3 (96.7, 99.8)   6.5 (3.8 to 9.1)      5.7 (−0.9 to 12.3)
   Non-trial participant                                593         646    91.8 (89.7, 93.9)   1                     1
  Ages 18--20                                                                                                        
   Trial participant (control)                          39          43     90.7 (82.0, 99.4)   24.2 (13.7 to 34.7)   17.7 (2.6 to 32.8)
   Non-trial participant                                163         245    66.5 (60.6, 72.4)   1                     1
  2015: full cohort                                                                                                  
  All ages                                                                                                           
   Trial participant (control)                          653         813    80.3 (77.6, 83.1)   11.8 (8.3 to 15.3)    6.9 (3.6 to 10.3)
   Non-trial participant                                1231        1797   68.5 (66.4, 70.7)   1                     1
  Ages 11--15                                                                                                        
   Trial participant (control)                          448         504    88.9 (86.2, 91.6)   4.8 (1.2 to 8.3)      2.4 (−1.3 to 6.1)
   Non-trial participant                                833         990    84.1 (81.9, 86.5)   1                     1
  Ages 16--17                                                                                                        
   Trial participant (control)                          186         269    69.1 (63.6, 74.7)   9.9 (3.1 to 16.7)     9.7 (2.6 to 16.8)
   Non-trial participant                                346         584    59.3 (55.4, 63.4)   1                     1
  Ages 18--20                                                                                                        
   Trial participant (control)                          19          40     47.5 (32.0, 63.0)   24.2 (7.7 to 40.6)    21.5 (4.9 to 38.1)
   Non-trial participant                                52          223    23.3 (18.4, 29.6)   1                     1
  2015: restricted cohort[†](#tblfn10){ref-type="fn"}                                                                
  All ages                                                                                                           
   Trial participant (control)                          653         803    81.3 (78.6, 84.0)   6.9 (3.5 to 10.4)     4.5 (1.3 to 7.6)
   Non-trial participant                                1231        1655   74.4 (72.3, 76.5)   1                     1
  Ages 11--15                                                                                                        
   Trial participant (control)                          448         503    89.1 (86.3, 91.8)   4.2 (0.7 to 7.8)      2.5 (−1.2 to 6.2)
   Non-trial participant                                833         982    84.8 (82.6, 87.1)   1                     1
  Ages 16--17                                                                                                        
   Trial participant (control)                          186         264    70.5 (65.0, 76.0)   5.3 (−1.5 to 12.1)    5.2 (−2.0 to 12.3)
   Non-trial participant                                346         531    65.2 (61.2, 69.3)   1                     1
  Ages 18--20                                                                                                        
   Trial participant (control)                          19          36     52.8 (36.5, 69.1)   16.2 (−2.0 to 34.3)   13.8 (−5.7 to 33.4)
   Non-trial participant                                52          142    36.6 (29.5, 45.5)   1                     1

School enrolment outcome was analysed in 2011 and 2015 and the analysis was stratified by age, in the full cohort and the cohort restricted to those enrolled in school in 2011.

\*Adjusted for socioeconomic status (coded dichotomously at median household asset index score), country of origin (South African vs Mozambican), educational attainment of household head (coded dichotomously at grade 12 attainment), gender of household head (male vs female), household size (coded linearly) and pre-2011 childbearing (yes vs no). Models that are not age-stratified are also adjusted for age coded in 2-year categories.

†Restricted to all young women who were enrolled in school in 2011.

aRD, adjusted risk difference; HPTN, HIV Prevention Trial Network; RD, risk difference.

Discussion {#s4}
==========

HPTN 068 found that cash transfers conditional on school enrolment did not influence HIV acquisition among young women in a rural South African setting. Due to unexpectedly high levels of school enrolment in both arms, the ability to explore schooling as a mechanism through which cash transfers could influence HIV acquisition was limited. Here, we found evidence to suggest that both Hawthorne effects and sample selection effects could threaten the external validity of these findings. Overall, trial participants were more likely to remain in school until graduation than non-participants. Differences in school enrolment status were already apparent at the beginning of the study, suggesting that the trial selection criteria likely pulled in young women with better school enrolment behaviours than those who were not enrolled as trial participants (sample selection effect). Differences in school enrolment grew larger as the trial progressed, and importantly remained strong even after restricting to those enrolled in school in 2011 when the trial started, suggesting the changes in enrolment status occurred during the trial itself (Hawthorne effect). Both sample selection and Hawthorne effects may have diminished the differences in school enrolment between study arms and is one plausible explanation for the overall null study effect. The HPTN 068 trial was designed to activate the HIV prevention effects of education by incentivising school attendance and retention in the intervention arm. With high levels of school attendance and retention across both arms of the trial, the ability to detect a trial effect was likely weakened.

Our findings that trial participation influenced school enrolment behaviour could plausibly be explained by several characteristics of the HPTN 068 study design and protocol. First, all participants were aware of the objective of the study: to retain young women in school to prevent HIV. This information could result in school enrolment behaviour change to align with perceived expectations of study staff or because young women were motivated to prevent HIV. Second, compared with non-participants, trial participants were exposed to different networks likely to be supportive of school enrolment. Adult fieldworkers showed interest in the schooling of participants with yearly in-person data collection and monthly in-school data collection. Data were collected in 'camps' wherein trial participants were transported to study offices annually for a half-day of surveys and blood tests, and entertaining activities during wait periods (eg, fingernail painting, photograph taking, magazine reading). This protocol could have fostered a cohesive group environment among trial participants resulting in positive peer pressure to maintain school enrolment. There is a growing body of evidence that interventions providing a safe space with adult mentorship and peer support can have positive outcomes for young women in sub-Saharan Africa,[@R24] a pathway that may have been activated with trial participation. Finally, trial participation provided access to certain health and social services that may have otherwise been inaccessible, including annual HIV and herpes simplex virus type 2 (HSV-2) testing and counselling, linkage to care for those who tested positive, and linkage to social work services for young women who reported experiences of sexual abuse. These services may have enabled young women who would have otherwise struggled with serious physical and mental health outcomes to remain in school.

Associations between trial participation and school enrolment were strongest in older age groups. The small differences observed in the youngest age group are understandable as they were under the age limit of compulsory education with requirements to remain in school regardless of trial influence. For the oldest age group, trial selection criteria for lower grade levels meant they were older than expected for their grade, and suggested a history of grade repetition or temporary dropout. That the trial protocol may have contributed to keeping older teens in school is significant as the transition to adulthood carries extremely high HIV risk.[@R23]

This study was fairly unusual in that data were available on key study outcomes for the underlying population from which study participants were drawn. The Agincourt HDSS routinely collects school enrolment data on all residents in the study area, and we were able to leverage those data to assess differences between trial participants and non-participants. The majority of epidemiological studies do not have the benefit of complete background data on the target population, and, as such, sample selection and Hawthorne effects are rarely empirically assessed.[@R5] However, when Hawthorne effects are assessed, the direction of the relationship between research participation and healthy outcomes tends to be positive, in line with our findings of improved school enrolment outcomes.

It is important to note that data on HIV incidence, the primary endpoint of HPTN 068, were not available for the underlying target population. We speculate that the improved schooling trajectories we observed in trial participants likely resulted in reduced risk of HIV acquisition.[@R17] Continued schooling is strongly associated with HIV prevention and reduced sexual risk outcomes in young women in sub-Saharan Africa,[@R18] and we observed lower HIV incidence (1.8%) than expected among trial participants (3%). However, we cannot say with certainty that the association between trial participation and school enrolment extended to HIV protection.

The potential for uncontrolled confounding requires that our results be interpreted cautiously. The differences we attribute to the Hawthorne effect were estimated in an observational data set. Initial screens for trial eligibility were performed based on age data maintained by the Agincourt HDSS, and 82% of the eligible young women approached went on to enrol in the study, a fairly high response rate.[@R17] Still, it is plausible that those who refused participation were different from those who consented in ways that were also related to future school enrolment trajectories. Although we controlled for key sociodemographic characteristics that we theorised could be related to both trial participation and school enrolment, the possibility for bias from unmeasured confounding remains.

We offer three key conclusions from this study. First, epidemiologists should give greater weight at the planning, analysis and dissemination stages to identifying how sample selection and Hawthorne effects can be minimised, assessed and discussed. Prioritising research with well-defined target populations in areas with ongoing background data collection (eg, HDSS centres) would improve researchers' abilities to empirically assess the external validity of their findings. Second, the sample selection effect we observed highlights how school-based samples can differ in important ways from non-school-based samples in terms of underlying risk. Interventions focused on school-going adolescents may not reach those most in need of prevention, an anticipated issue that was ultimately difficult to avoid given the HPTN 068 design. Third, the Hawthorne-specific findings suggest that aspects of the HPTN 068 protocol could potentially be adapted for school retention interventions to prevent HIV. If the relationship we observed is causal, the trial protocol increased school enrolment at a magnitude similar to targeted cash transfer interventions and other fairly resource-intensive school retention interventions in sub-Saharan Africa,[@R21] despite the actual contact with the young women being limited to annual visits. Future work should examine key elements of the study protocol---adult mentorship, peer support, school attendance monitoring, messaging around the link between school and HIV, routine HIV/sexually transmitted infection testing and linkage to care---to better understand their relationship with school retention and HIV acquisition.
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